Back Pain Doctor
Sacroiliac Joint (SIJ) Pain
Go deeper
This page is the summary. There is a full section on this site covering the sacroiliac joint, its ligaments and lumbopelvic instability in depth — including a staged rehabilitation programme with the trial protocols behind it, and an evidence review of every treatment offered for this problem.
- The sacroiliac joint section — the hub, with the evidence at a glance
- The joint and its ligaments — and why ligamentous pain is about as common as pain from inside the joint
- Lumbopelvic instability — what the construct supports, and what it does not
- Getting the diagnosis right — the provocation cluster, imaging, and diagnostic blocks
- The rehabilitation programme — four phases with dosage and progression criteria
- Protocols for clinicians — trial parameters and outcome measures
- PRP at the sacroiliac joint — including the double-blind trial that favoured corticosteroid
- Prolotherapy at the sacroiliac joint — the strongest single result here, and the sobering real-world figure
- Shockwave and EMTT — one sham-controlled trial, and a device with none
- Referral, ablation and surgery — the procedures not done here, and their evidence
Why the SIJ deserves careful attention
The sacroiliac joints connect the sacrum at the base of the spine to the pelvis. They transfer load between the trunk and legs during standing, walking, lifting and single-leg tasks. SIJ-related pain can follow pregnancy, a fall or motor-vehicle accident, a change in training or work load, or previous lumbar fusion. It can also arise without one clear event.
Pain in this region does not automatically mean the SIJ is the source. Lumbar disc or facet pain, hip joint pathology, gluteal tendon pain, nerve-root pain and inflammatory arthritis can look very similar. The point of assessment is to identify the most likely pain generator, screen for important alternatives and make a plan that fits the findings.
How we assess suspected SIJ pain
Diagnosis is based on a pattern, not a single test. We bring together your pain history, aggravating activities, examination of the lower back and hips, neurological assessment where relevant, and a cluster of SIJ pain-provocation tests. A cluster can increase or decrease suspicion, but it cannot by itself distinguish pain from inside the joint from pain in the surrounding dorsal ligaments.
Scans can be useful to exclude or investigate other problems — including inflammatory sacroiliitis, fracture, infection, tumour or hip and lumbar pathology — but routine imaging does not reliably identify a painful SIJ. When the diagnosis remains uncertain and a procedure is being considered, an appropriately image-guided local-anaesthetic injection can sometimes be used as a diagnostic tool.
Symptoms such as fever, unexplained weight loss, a history of cancer, significant trauma, new bowel or bladder disturbance, saddle numbness, progressive leg weakness, or marked morning stiffness with other inflammatory features need prompt medical assessment.
A rehabilitation-led SIJ plan
Most people do not need an injection. The first step is to reduce the activities that repeatedly flare symptoms without becoming inactive, then rebuild tolerance through a specific programme. This usually targets trunk control, hip strength, gluteal function, graded single-leg loading and the practical tasks that matter to you — such as rolling in bed, stairs, walking, lifting or returning to sport.
For people with a clear pelvic load-transfer problem, a period of targeted lumbo-pelvic rehabilitation before any regenerative injection is sensible. The original prolotherapy protocol described by Sydney Spine & Pelvis required a three-month stability programme first; that principle remains useful because many people improve without a procedure. Progress is judged by function and symptom response, not by trying to make the pelvis “perfectly aligned”.
When an injection may be discussed
If pain continues despite a well-delivered rehabilitation plan, we revisit the diagnosis before escalating care. An injection may be considered to clarify the pain source, settle a clearly defined target enough to allow rehabilitation, or — in a small, carefully selected group — as part of a broader plan for persistent SIJ-related pain.
Injections given here are performed under ultrasound guidance, which suits the posterior ligamentous complex and the caudal part of the joint. Ultrasound does not on its own confirm that a needle sits inside the joint cavity, and the sacroiliac cavity is difficult to enter under any modality. Where placement inside the joint has to be certain, or the target cannot be reached safely under ultrasound, the injection is referred to a radiologist to perform under CT guidance. Standalone diagnostic blocks, lateral branch blocks and radiofrequency ablation are not performed here and are a referral to a pain medicine specialist.
PRP and dextrose prolotherapy are sometimes proposed for SIJ pain because of their potential biological effects in joint and ligament tissue. The research is still limited: recent systematic reviews found only a small number of randomised and observational PRP studies and judged the overall certainty low, with a weak recommendation. One small randomised trial of intra-articular dextrose prolotherapy reported longer-lasting pain relief than steroid injection, but this is not enough to make it a routine first-line treatment. PRP has not been shown conclusively to be superior to prolotherapy for SIJ pain.
That means we do not present either treatment as a way to “tighten ligaments”, repair the SIJ, or guarantee pain relief. If either is appropriate, the discussion includes the uncertainty in the evidence, expected time course, risks, out-of-pocket cost and the rehabilitation required alongside it.
Evidence reviewed
- Multispecialty consensus guidelines on SIJ complex pain (Pain Medicine 2025;26(12):817-917) — 21 endorsing organisations, complete committee consensus on all 21 questions. Supports a history-and-examination approach using a test cluster while noting that negative tests carry greater predictive value than positive ones; describes the evidence for imaging as unclear or negative; finds intra-articular and extra-articular pathology about equally common; and rates the evidence for both dextrose prolotherapy and PRP as weak, supporting at least three months of relief.
- Systematic review of PRP and stem-cell SIJ injections (Current Pain and Headache Reports, 2025) — identified limited clinical evidence and graded the recommendation for PRP as weak.
- Randomised trial of dextrose prolotherapy versus steroid injection for SIJ pain (2010) — a small trial that found longer-term pain relief with prolotherapy; further research is needed to confirm safety and establish the best protocol.
Common symptoms
- Pain near the back of the pelvis or buttock
- Pain aggravated by rolling in bed, stairs, single-leg loading or prolonged standing
- Pain that may refer into the groin, hip or upper thigh
- Symptoms after pregnancy, trauma, lifting or repetitive loading
Commonly seen in
Evidence for twelve treatment options in sacroiliac joint (sij) pain
This is not a fixed ladder or a package of treatments. Every option is assessed independently against this diagnosis, including treatments with limited direct research that may still be reasonable for a clearly defined tissue target. The evidence level, likely benefit, risks, cost and alternatives are weighed at consultation.
Foundation — diagnosis, education and rehabilitation
The part of care with the broadest relevance. For many people it is enough on its own; other options are judged against it, not automatically added after it.
Diagnosis, education and progressive rehabilitation Working out what is driving the pain, explaining what your imaging does and does not mean, and building a graded loading plan you can actually follow. Core care
What it involves
Assessment to identify the likely pain source, an explanation of what the diagnosis means, adjustment of the loads that aggravate it, and a progressive strength and conditioning plan — with weight management where that is clinically relevant.
What the evidence shows
This is the only treatment for sacroiliac and pelvic girdle pain with durable randomised evidence, and the trials also show why most versions of it fail. A randomised controlled trial of 81 women with pelvic girdle pain after pregnancy, with a blinded assessor and no dropouts, compared 20 weeks of physiotherapy with specific stabilising exercises against individualised physiotherapy without them: disability fell by more than half in the exercise group with negligible change in controls, and the median group difference in evening pain was 30 mm on a 100 mm scale (Stuge, Spine 2004). At two years, 85% of the exercise group had minimal disability against 47% of controls, though the authors note the between-group differences disappeared after adjusting for one-year score level (Stuge, Spine 2004). A published comparison against the negative trial of the same era identifies the design features that separate them: local muscles first with global added gradually, supervised and corrected in person, individualised in choice, order and dosage, and pain explicitly avoided (Stuge, Man Ther 2006). The counterweight is real: a 2025 narrative review found five of six eligible studies reported NO significant short-term pain change from motor control exercise in this population, and judged the exercises used generally unspecific (Zitti, Healthcare 2025). The 2025 consensus guidelines note that the non-interventional evidence in sacroiliac joint complex pain is indirect, extrapolated mostly from general low back pain studies (McCormick and Cohen, Pain Med 2025).
Pairing reviewed 2026-09-03.
Where it fits for you
The whole plan starts here, and the delivery matters as much as the content — a printed sheet done unsupervised is closer to the trial that found nothing than to the one that worked. Twenty weeks is the reference duration, progression is by criteria rather than by calendar, and exercises that hurt are modified rather than pushed through. Nobody will be told their pelvis is out of alignment; the palpation tests that claim to detect that have never been shown to measure anything.
Muscle and symptom-modifying options
Useful only when the examination identifies the tissue they target or when short-term pain control creates a useful rehabilitation window.
Wet needling and trigger point injection (trigger point injection) A fine needle into a tender band of muscle, with a small volume of dilute glucose solution injected through it. Worth discussing
What it involves
The needle is placed into the tender muscle band and a small volume of 5% glucose with 0.02-0.08% lignocaine is injected. Often done in the same visit as your assessment, and usable where the tender area sits deeper. Dry needling — the same technique with nothing injected — is not offered here.
What the evidence shows
For myofascial pain, trigger point injection performed as well as shockwave in head-to-head comparison — a meta-analysis of 10 trials found shockwave better than sham and ultrasound but NO better than trigger point injection, dry needling or laser (Zhang, Arch Phys Med Rehabil 2020). Trials of needling in myofascial pain are small and generally low quality.
Pairing reviewed 2026-08-30.
Where it fits for you
Directed at a tender muscle band that reproduces part of your pain, alongside the loading work. Not a treatment for the joint, disc or nerve itself.
Ultrasound-guided injections Guidance means we can see the needle reach the target. What goes into the needle depends on the diagnosis. Good support
What it involves
The injection is performed under ultrasound so the needle can be watched into the target structure. What is injected is decided by the diagnosis — and corticosteroid is used sparingly, for the reasons set out below.
What the evidence shows
Ultrasound improves needle-placement accuracy, but guidance is not a treatment in itself: benefit depends on a valid injectable target and what is injected. Condition reviewed: sacroiliac joint pain.
Evidence source: Oo et al., ultrasound-guided injection systematic review (2024)
Pairing reviewed 2026-08-30.
Where it fits for you
For sacroiliac joint pain, an ultrasound-guided injection is considered only when there is a specific diagnostic question or a separate joint, bursa, sheath or nerve target. The injectate and purpose are stated before treatment.
V-ACTOR vibration therapy (vibration therapy) Low-frequency vibration applied over tender muscle. Not a shockwave, despite sharing the machine. Plausible — no studies
What it involves
A vibration handpiece is moved over the tender muscle and fascia for a few minutes. It runs from the same STORZ MASTERPULS icon console as radial shockwave but is a separate handpiece delivering a different, gentler form of energy. No needles, no anaesthetic, no downtime.
What the evidence shows
No published clinical trial of this device in this condition. It is a vibration handpiece delivered from the same console as radial shockwave, and the rationale is myofascial rather than tendon- or bone-directed.
Pairing reviewed 2026-08-30.
Where it fits for you
A comfort measure used within a session where muscular tightness is limiting movement. Never the reason for the appointment, and not a substitute for the treatments that do have evidence.
Energy-based treatment options
Radial pressure wave, focused shockwave and EMTT have different targets and different evidence. They are assessed separately rather than treated as one category.
Radial or focused shockwave? Read the overviewRadial shockwave (radial pressure wave) Broad treatment across tender muscle and fascia, close to the surface. Evidence is for focused
What it involves
A handpiece is moved over the tender tissue while ballistic pressure pulses are delivered, using a transmitter head chosen for the tissue — including heads shaped for fascia and for the muscle either side of the spine. The pulse is strongest at the skin and weakens with depth, so this is mainly a myofascial treatment, though it can reach deeper in some areas. No anaesthetic, no downtime, usually a course of sessions about a week apart.
What the evidence shows
Shockwave has been tested at this joint, but with a focused device. Ninety women with postpartum sacroiliac dysfunction were randomised to focused shockwave, manual therapy, or both: focused shockwave gave better disability scores than manual therapy at one week, was behind manual therapy on pain by two weeks, and the combination did best overall (Tan, J Orthop Surg Res 2024). A review of shockwave for low back pain identifies the sacroiliac joint, the facet joints and myofascial trigger points as where the literature has concentrated, and treats the radial and focused devices as having different properties (Schoder, Orthopadie 2025); its authors run shockwave centres, which is worth weighing. A further randomised report of shockwave for sacroiliac joint pain appeared only as a letter (Notarnicola, J Biol Regul Homeost Agents 2020).
Pairing reviewed 2026-09-13.
Where it fits for you
For the tender gluteal and lumbar muscle around the joint, which is often a real part of sacroiliac pain. The joint itself sits too deep for a radial pressure wave to reach, and the injections set out above are the better-evidenced options here.
Focused shockwave (ESWT) A true shock wave converging at depth — for tendon, joint, ligament and bone. Two small trials, used with rehab
What it involves
A focused system generates an acoustic shock wave that converges at a focal point set at a defined depth, concentrating the energy where the target is. This is the form we use for tendon, joint, ligament and bone. Typically four to six sessions about a week apart, no anaesthetic and no formal downtime.
What the evidence shows
Unlike the rest of the spine, this joint has been tested, and it now has two randomised trials that disagree about which outcome moves. A prospective randomised sham-controlled trial of 30 patients delivered 2,000 shocks at the maximum tolerated energy (flux density 0.09-0.25 mJ/mm2) with the probe perpendicular to the posterior joint line, against an active sham delivering the same shock count with the probe parallel to the line. Pain fell from 6.42 (95% CI 5.19-7.66) to 3.64 (2.29-4.99) at four weeks in the treated group and did not change in the sham group, with a significant between-group difference at four weeks (3.64 versus 6.18). Oswestry Disability Index improved in the treated group but NOT significantly, and did not separate from sham at any point (Moon, J Back Musculoskelet Rehabil 2017). A second trial randomised 90 postpartum women with sacroiliac joint dysfunction to focused shockwave, manual therapy, or both. It found the mirror image: Oswestry Disability Index lower than manual therapy at one week (p<0.001), but pain relief INFERIOR to manual therapy by two weeks. The combined arm was the strongest, with the highest cure rate at 73.3% against 66.7% improvement for shockwave alone, and no adverse events in any arm over two months (Tan, J Orthop Surg Res 2024). That trial had no sham, and an author is affiliated with a shockwave device manufacturer. Neither trial followed anyone beyond four weeks. The remaining literature is a letter in a journal of contested standing (Notarnicola, J Biol Regul Homeost Agents 2020) and a narrative review whose senior authors run private shockwave centres (Schoder, Orthopadie 2025).
Pairing reviewed 2026-09-04.
Where it fits for you
Used alongside the rehabilitation programme rather than as a course of its own — the arrangement the evidence actually supports, since the strongest arm of the 2024 trial was shockwave combined with hands-on treatment. The window it suits is the one where pain is the obstacle to doing the loading work. Non-invasive and low-risk, with no serious adverse events in either trial, which is a fair reason to try it before an injection rather than after. The expectation set beforehand is a short-term effect on pain, function or both, of a size that makes the programme easier to do; the two trials disagree about which of those moves, and neither goes past four weeks, so nothing is claimed about lasting change. A short course with a defined review point, not an open-ended series. Focused rather than radial, because the joint line and its interosseous ligament sit deeper than a radial device reaches; radial has a separate myofascial role here.
EMTT (magnetotransduction therapy) High-energy magnetic pulses applied over the area. Painless, no contact. Plausible — no studies
What it involves
You sit with the applicator positioned over the area for a short session. Painless, no gel or contact required, and usually delivered as a course — commonly alongside shockwave.
What the evidence shows
There are no published randomised trials of EMTT in this condition, or in any musculoskeletal condition, that we can point to. The supporting work is laboratory work: EMTT increased tenocyte proliferation, migration and collagen expression in cultured human tendon cells (Mancini, Int J Mol Sci 2025). The nearest human evidence for a related electromagnetic therapy is negative — a randomised trial of pulsed electromagnetic field therapy added to eccentric exercise for Achilles tendinopathy found no improvement in outcome scores or tendon neovascularity over eccentric exercise alone (Ko, Orthop J Sports Med 2024).
Pairing reviewed 2026-08-30.
Where it fits for you
Offered only as an adjunct alongside treatment that does have evidence, never as the plan itself, and only after that gap is explained. Much of the EMTT literature is manufacturer-affiliated, which is part of why we describe it this way.
Biologic and joint injection options
Each injection is assessed independently for the named diagnosis. Cost, uncertainty, likely benefit, risks and alternatives are part of the decision.
Platelet-rich plasma (PRP) Your own blood, concentrated and injected under ultrasound guidance. Limited SIJ evidence
What it involves
Blood is taken from your arm, spun to concentrate the platelets, and injected into the target under ultrasound guidance in the same appointment.
What the evidence shows
The two randomised trials disagree, and the better-designed one is the negative one. A DOUBLE-BLIND randomised trial at two university spine centres enrolled 26 patients who had more than 80% relief from a fluoroscopically guided diagnostic block, then randomised them to intra-articular PRP or corticosteroid: both groups improved, but the steroid group reported lower pain at one, three and six months and had significantly more responders at one and three months (Chen, Pain Med 2022). Against that, an open-label prospective randomised trial of 40 patients found PRP clearly better, with median pain at three months of 1 (IQR 1-3) versus 5 (IQR 3-5) for steroid, p=0.0002 (Singla, Pain Pract 2017) - but participants and the injector were unblinded and entry criteria were looser. Four systematic reviews reach the same place from different starting points: evidence rated VERY LOW quality by GRADE from three eligible studies, with the single RCT's odds ratio spanning 4.65 to 298.69 (Burnham, Pain Med 2020); level IV, weak recommendation (Manchikanti, Curr Pain Headache Rep 2025); not enough to support PRP over the corticosteroid standard of care (Goodwin, Regen Med 2023); inconsistent and insufficient evidence for or against, with only five of seven studies reaching 50% efficacy (Rothenberg, Regen Med 2021). The 2025 multispecialty consensus guidelines, endorsed by 21 organisations, state there is WEAK evidence supporting PRP for at least three months of relief (McCormick and Cohen, Pain Med 2025). Note also that both randomised trials injected inside the joint; PRP into the posterior ligaments has never been tested against a control, even though the guidelines find intra-articular and extra-articular pathology about equally common.
Pairing reviewed 2026-09-03.
Where it fits for you
Used here for sacroiliac pain that has not settled with an adequately delivered rehabilitation programme — not as a first step, and only once the diagnosis has been characterised, including which part of the complex is suspected, because that determines the target. Injections are given under ultrasound guidance, which suits the posterior ligamentous structures well but does not on its own confirm placement inside the joint cavity. The Chen trial is stated explicitly at consent rather than omitted: for most people the comparison that matters is against repeated cortisone, and one good trial found cortisone did better.
Prolotherapy (dextrose) A course of dextrose injections into and around the structure and its attachments. Best studied injectable here
What it involves
Hypertonic dextrose is injected at the tender ligament and tendon attachments, and into the joint where relevant, usually as a series of treatments a few weeks apart.
What the evidence shows
This has the longest trial record of any injectable at this joint, and the record runs from striking to sobering. A randomised controlled trial of 48 patients, all with block-confirmed sacroiliac pain of at least three months that had failed medical treatment, compared fluoroscopically guided intra-articular dextrose prolotherapy with triamcinolone, fortnightly to a maximum of three injections. Both were indistinguishable at two weeks; by 15 months the cumulative incidence of at least 50% pain relief was 58.7% (95% CI 37.9-79.5) with prolotherapy against 10.2% (95% CI 6.7-27.1) with steroid, log-rank p<0.005 (Kim, J Altern Complement Med 2010). It is a single centre, has not been replicated in sixteen years, and the authors themselves called for confirmation of safety and validation of the protocol. The ligamentous evidence is weaker: a prospective UNCONTROLLED series of 25 patients given CT-guided hypertonic dextrose into the dorsal interosseous ligament, three injections six weeks apart, reported positive outcomes in 76% at three and twelve months but only 32% at 24 months, with attendance falling at later follow-up (Cusi, Br J Sports Med 2010). The most realistic figure comes from a retrospective cohort of 103 patients given 15% dextrose in lidocaine in a Veterans Affairs clinic: only 24 (23%) reached a minimum clinically important improvement at a median 117 days (Hoffman, Complement Ther Med 2018). The 2025 multispecialty consensus guidelines rate the evidence WEAK, supporting at least three months of relief (McCormick and Cohen, Pain Med 2025).
Pairing reviewed 2026-09-03.
Where it fits for you
Considered where the diagnosis is characterised and a three-month stability programme has not held — the prerequisite built into the original Sydney protocol, and the defensible sequence. Delivered under ultrasound guidance, which suits the posterior ligamentous target; note that the Sydney ligament protocol used CT and the randomised intra-articular trial used fluoroscopy, so neither studied protocol is reproduced exactly, and where the target requires CT the injection is referred to a radiologist rather than approximated here. One injection first, not a pre-booked course: in the largest cohort a 15-point Oswestry improvement before the second injection predicted eventual responder status with 92% sensitivity and 80% specificity, so a first injection that does little is a reason to stop rather than to continue. Both the Kim figures and the Hoffman figures are given, not just the flattering one. The treatment works by provoking inflammation, so several days of increased soreness is expected rather than a complication.
Viscosupplementation (hyaluronic acid) A gel-like injection into an arthritic joint. Widely used, and genuinely contested. No randomised SIJ trials
What it involves
One or a short series of hyaluronic acid injections into the joint under ultrasound guidance.
What the evidence shows
There is no randomised trial of hyaluronic acid in the sacroiliac joint. What exists is small and non-randomised: a retrospective comparison of 60 people found viscosupplementation held its pain and disability gains out to six months, behind PRP and ahead of cortisone at that point (Yadav, Cureus 2026), and an early series of four people reported 40 to 67% less pain at twelve to sixteen weeks (Srejic, Reg Anesth Pain Med 1999). A systematic review of hyaluronic acid in every joint except the knee, which covered the sacroiliac joint, found improvement from baseline but limited evidence of superiority over placebo and none over cortisone (Colen, BioDrugs 2012).
Pairing reviewed 2026-09-07.
Where it fits for you
Occasionally raised where cortisone has been used repeatedly. PRP is the better-studied injection at this joint and is discussed first.
Nerve-targeted options
Relevant when examination identifies a superficial neuropathic pattern or a compressed peripheral nerve—not simply because pain is present.
Lyftogt perineural therapy (perineural injection therapy) A series of small dilute dextrose injections just under the skin, over tender superficial nerves. Aimed at the cluneal nerves
What it involves
Small injections of low-concentration dextrose, usually 5%, placed just beneath the skin along tender superficial nerves. Given as a series of short sessions.
What the evidence shows
No trial has tested this treatment at the sacroiliac joint, and it is not aimed at the joint. What makes it relevant here is that the superior cluneal nerves cross the iliac crest a few centimetres above the joint, run close to the skin, and cause pain in the same area: in 36 people with superior cluneal nerve entrapment treated with ultrasound-guided dextrose around the nerve, 77.7% improved initially, with about a quarter relapsing (Wu, Insights Imaging 2023). A narrative review agrees the injection helps, while noting that no trial has compared techniques or injectates (Wu, Pain Physician 2022). Both used ultrasound-guided hydrodissection around the nerve rather than the series of small injections under the skin described here.
Pairing reviewed 2026-09-16.
Where it fits for you
Considered where examination finds tender, hypersensitive skin over the iliac crest or upper buttock, which points to a cluneal nerve rather than to the joint. Not offered for sacroiliac pain in general.
Ultrasound-guided nerve hydrodissection Fluid placed around a nerve to free it from the surrounding tissue. Only if relevant
What it involves
Under ultrasound, fluid is placed in the plane around the nerve to separate it from the tissue that is tethering or compressing it.
What the evidence shows
No trial has tested hydrodissection of the sacroiliac joint itself, and a scoping review of the technique for joint pain that searched the sacroiliac joint among others found its signals elsewhere (Leahy, Front Pain Res 2026). The nerves alongside the joint have been studied. The superior cluneal nerves cross the iliac crest just above the sacroiliac joint and are a recognised cause of pain in the same area: in 36 people with superior cluneal nerve entrapment, ultrasound-guided dextrose hydrodissection gave initial treatment success in about 78%, a quarter of whom later relapsed, with relapse more common in those with scoliosis (Wu, Insights Imaging 2023). A review of the nerve agrees that ultrasound-guided injection relieves symptoms but notes that no trial has compared the techniques or the fluids used (Wu, Pain Physician 2022).
Pairing reviewed 2026-09-15.
Where it fits for you
Only where the examination points to a nerve over the iliac crest rather than to the joint — tenderness a few centimetres out from the midline that reproduces your usual pain is the clue. This treats a condition that mimics sacroiliac pain, not the joint itself, and the sacroiliac joint is treated by the options higher up this page.
This is general information only and suitability is assessed individually. Treatments with limited or condition-dependent evidence may still be discussed, but only with clear explanation of the uncertainty, the expected benefit, risks, cost and alternatives. Red flags, progressive neurological symptoms or suspected serious pathology require a different pathway.
Every treatment above is described in full on the non-surgical treatments page, including what each one is used for and what the evidence supports. Ratings apply to the named diagnosis; an adjacent muscle, tendon, joint or nerve problem is assessed as a separate target.
Corticosteroid injection is reviewed separately for each diagnosis.
Cortisone reliably reduces pain in the short term, and that can be genuinely useful when pain is stopping you sleeping or moving enough to rehabilitate. Beyond that window the picture changes. A systematic review of 41 randomised trials and 2,672 participants found that corticosteroid injection reduced pain in the short term but that the effect reversed at intermediate and long term; in pooled analysis for lateral epicondylalgia the short-term effect was large (SMD 1.44, 95% CI 1.17 to 1.71) while no intervention was favoured at 26 weeks (-0.40, -0.67 to -0.14) and at 52 weeks (-0.31, -0.61 to -0.01) (Coombes, Lancet 2010). In a randomised trial in lateral epicondylalgia, 83 per cent of the corticosteroid group had completely recovered or much improved at one year against 96 per cent given a placebo injection, and recurrence ran at 54 per cent against 12 per cent; adding physiotherapy made no significant difference at one year (Coombes, JAMA 2013). In joints, repeated corticosteroid injections have been associated with cartilage loss. It does not repair anything.
So we do not build treatment plans around it. Where an injection is the right call, we review the specific diagnosis and target, discuss what is being injected and why, keep the number low, and pair it with the loading work that changes the longer-term course.
When we would still consider it
- Pain severe enough to block rehabilitation
- A clear inflammatory or bursal target on imaging
- A specific short-term goal — a trip, a procedure, a return to work
- Diagnostic use, where the response tells us where the pain is coming from
When a cortisone injection is worth doing, and when it is not
Other back conditions
Pain in the same area can come from more than one source, and the label matters less than what the examination and history point to. These are the other guides for this region.
Frequently asked questions
Is sacroiliac pain easy to diagnose?
Can sacroiliac pain refer down the leg?
What is the first-line treatment for SIJ pain?
Are PRP or prolotherapy proven treatments for SIJ pain?
Ready for a clearer plan for your back or musculoskeletal pain?
Book an assessment with Dr Joshua Hatch.
Your assessment focuses on understanding the likely source of your pain and the most appropriate non-surgical options for your diagnosis, with the aim of reducing pain and improving function.
Book an appointment